SCHEMBL4849688

SCHEMBL4849688

CCN(CC)CCOc1ccc(-c2ccccc2C)cc1C=CC(=O)c1ccccc1CN(C)C

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 2/20 0.41
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
MAOB P27338 7/20 0.39
MCHR1 Q99705 5/20 0.39
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
MAOA P21397 6/20 0.38
SCN1A P35498 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN3A Q9NY46 1/20 0.37
APP P05067 4/20 0.37
DRD2 P14416 1/20 0.37
DRD1 P21728 1/20 0.37
DRD3 P35462 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4845311 0.95 MAOB (0.42) MAOBBCHEACHEMAOAAPP
SCHEMBL4847450 0.93 SLC6A9 (0.43) SLC6A9KDM4EALDH1A1MCHR1BCHE
SCHEMBL4849684 0.90 SLC6A9 (0.44) SLC6A9KDM4EALDH1A1LMNAMAOB
SCHEMBL4850218 0.90 SLC6A9 (0.44) SLC6A9KDM4EALDH1A1LMNAMAOB
SCHEMBL4854470 0.89 KDM4E (0.43) SLC6A9KDM4EALDH1A1BCHEACHE
SCHEMBL4852335 0.89 SLC6A9 (0.40) SLC6A9KDM4EALDH1A1MAOBMCHR1
SCHEMBL4854695 0.87 SLC6A9 (0.43) SLC6A9KDM4EALDH1A1MCHR1BCHE
SCHEMBL4852369 0.86 HRH1 (0.41) SLC6A9KDM4EALDH1A1LMNAMCHR1
SCHEMBL4851092 0.86 ALDH1A1 (0.42) SLC6A9KDM4EALDH1A1MCHR1BCHE
SCHEMBL4852558 0.85 MAOB (0.42) SLC6A9MAOBBCHEACHEMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed